Single-cell genomics has revealed AD-associated vulnerability in specific cell types, such as somatostatin (SST+) GABAergic inhibitory neurons, and distinct gene expression programs that distinguish vulnerable individuals [8, 15–20]. This evidence concerns the gene SST and Alzheimer disease.